Pierre Loap

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Hodgkin Lymphoma

Diffusion Weighted

Top Venues

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Acta oncologica (Stockholm, Sweden)

Future oncology (London, England)

The breast journal

This page only lists publications with an associated author ORCID identifier.

Publications

Pierre Loap, Jeremi Vu Bezin, Ludovic De Marzi, Youlia Kirova
Determinants of radiation dose to immune cells during breast radiotherapy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2024)
Pierre Loap, Youlia Kirova
Post-mastectomy reirradiation for ipsilateral T3N0M0 breast tumor relapse: a population-based study. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 200 (4) (2024)
Pierre Loap, Youlia Kirova
Post-mastectomy reirradiation for ipsilateral T3N0M0 breast tumor relapse: a population-based study. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2024)
Pierre Loap, Youlia Kirova
Post-mastectomy reirradiation for ipsilateral T3N0M0 breast tumor relapse: a population-based study. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 200 (4) (2024)
Pierre Loap, Natacha Johnson, Rudy Birsen, Justine Decroocq, Youlia Kirova
Tolerance of radiotherapy with concomitant glofitamab in diffuse large B cell lymphoma: a case report. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2024)
Pierre Loap, Jeremi Vu-Bezin, Ludovic De Marzi, Youlia Kirova
Proton therapy reduces the effective dose to immune cells in breast cancer patients. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2024)
Pierre Loap, Jeremi Vu-Bezin, Virginie Monceau, Sophie Jacob, Alain Fourquet, Youlia Kirova
Dosimetric evaluation of the benefit of deep inspiration breath hold (DIBH) for locoregional irradiation of right breast cancer with volumetric modulated arctherapy (VMAT). Acta oncologica (Stockholm, Sweden) (2023)
Pierre Loap, Ester Orlandi, Ludovic De Marzi, Viviana Vitolo, Amelia Barcellini, Alberto Iannalfi, Rémi Dendale, Youlia Kirova, Alfredo Mirandola
Cardiotoxicity model-based patient selection for Hodgkin lymphoma proton therapy. Acta oncologica (Stockholm, Sweden) 61 (8) (2022)
Pierre Loap, Benjamin Nicaise, Fatima Laki, Delphine Loirat, Jean-Yves Pierga, Alain Fourquet, Youlia Kirova
Clinical outcomes of curative-intent multimodal management of chemorefractory nonmetastatic inflammatory breast cancer. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2022)
Giulia Fontana, Amelia Barcellini, Dario Boccuzzi, Mattia Pecorilla, Pierre Loap, Lorenzo Cobianchi, Viviana Vitolo, Maria Rosaria Fiore, Alessandro Vai, Guido Baroni, Lorenzo Preda, Sara Imparato, Ester Orlandi
Role of diffusion-weighted MRI in recurrent rectal cancer treated with carbon ion radiotherapy. Future oncology (London, England) 18 (22) (2022)
Pierre Loap, Alfredo Mirandola, Ludovic De Marzi, Viviana Vitolo, Amelia Barcellini, Alberto Iannalfi, Rémi Dendale, Youlia Kirova, Ester Orlandi
Cardiac conduction system exposure with modern radiotherapy techniques for mediastinal Hodgkin lymphoma irradiation. Acta oncologica (Stockholm, Sweden) 61 (4) (2022)
Pierre Loap, Nicolas Tkatchenko, Farid Goudjil, Madison Ribeiro, Brian Baron, Alain Fourquet, Youlia Kirova
Cardiac substructure exposure in breast radiotherapy: a comparison between intensity modulated proton therapy and volumetric modulated arc therapy. Acta oncologica (Stockholm, Sweden) 60 (8) (2021)
Pierre Loap, Youlia Kirova
The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 197 (6) (2021)
Pierre Loap, Fatima Laki, Philippe Beuzeboc, Alain Fourquet, Youlia M Kirova
Five-year outcomes in patients treated with surgery and radiotherapy for primary neuroendocrine neoplasm of the breast. The breast journal 27 (10) (2021)
Pierre Loap, Delphine Loirat, Frederique Berger, Kim Cao, Francesco Ricci, Anne Jochem, Laurence Raizonville, Veronique Mosseri, Alain Fourquet, Youlia Kirova
Combination of Olaparib with radiotherapy for triple-negative breast cancers: One-year toxicity report of the RADIOPARP Phase I trial. International journal of cancer 149 (10) (2021)